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Abstract
Objective: This study was conducted to assess treatment decision-making capacity (TDMC) in a child and adolescent psychiatric
sample and to verify possible associations between TDMC, psychiatric symptom severity, and cognitive functioning.
Methods: Twenty-two consecutively recruited patients hospitalized for an acute mental disorder, aged 11–18 years, un-
derwent measurement of TDMC by the MacArthur Competence Assessment Tool for Treatment (MacCAT-T). The
MacCAT-T interview focused on patients’ current treatment, which comprised second-generation antipsychotics (45.5%),
first-generation antipsychotics (13.6%), antiepileptic drugs used as mood stabilizers or lithium carbonate (45.5%), selective
serotonin reuptake inhibitors (32%), and benzodiazepines (18%). We moreover measured cognitive functioning (Wechsler
Intelligence Scale for Children III) and psychiatric symptom severity (Brief Psychiatric Rating Scale v 4.0).
Results: Patients’ TDMC varied within the sample, but MacCAT-T scores were good in the sample overall, suggesting that
children and adolescents with severe mental disorders could be competent to consent to treatment. The TDMC proved independent
of psychiatric diagnosis while being positively associated with cognitive functioning and negatively with excitement.
Conclusion: The MacCAT-T proved feasible for measuring TDMC in a child and adolescent psychiatric sample. TDMC in
minors with severe mental disorders was not necessarily impaired. These results deserve reconsidering the interplay between
minors and surrogate decision-makers as concerning treatment decisions.
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Introduction
Data on informed consent decision-making in child andadolescent psychiatry are scarce. Involuntary treatment and
surrogate decision-making are also common in adolescent psy-
chiatric populations, and the need for consistent legal instruments
and systematic analyses of such coercive practices has been re-
cently advocated ( Jendreyschak et al. 2014).
Several studies focusing on adult psychiatric patients’ treatment
decision-making capacity (TDMC) found a significant role played
by cognitive factors (Okai et al. 2007; Mandarelli et al. 2012).
Psychiatric symptom severity, rather than diagnosis, as well as
metacognition, proved to be associated with TDMC in adult psy-
chiatric populations. Nonetheless, whether and how these factors
play a role also in child and adolescent treatment decision-making
is unclear. Having such information is crucial because it could
provide empirical evidence to verify child and adolescent capacity
to accept or refuse their own treatment as well as to usefully interact
with surrogate decision-makers.
No studies specifically aimed at evaluating child and adolescent
capacity to give informed consent to psychiatric treatment are
available, while two studies focused on informed consent to clinical
research. Among these, a methodological study (Hein et al. 2012)
proposed a modified version of the MacArthur Competence As-
sessment Tool for Clinical Research (MacCAT-CR) for assessing
capacity to give consent to clinical research in children and ado-
lescents. A pilot study (Koelch et al. 2010) from a German research
group on 12 children with ADHD or conduct disorder proved
the MacCAT-CR useful for evaluating capacity to consent to a
pharmacological trial. Moreover, the MacCAT-CR assessment
showed that clinical judgments of capacity to consent to pharma-
cological research frequently were unconfirmed when using a
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specific assessment tool such as the MacCAT-CR semistructured
interview, thus suggesting the need for specific evaluations (Koelch
et al. 2010).
The first research hypothesis of the present study was that the
MacArthur Competence Assessment Tool for Treatment (MacCAT-T)
(Grisso et al. 1997), which proved useful in adults, could also be
suitable in a child and adolescent psychiatry setting. The second
hypothesis was that cognitive functioning as well as psychiatric
symptom severity was associated with the ability to provide informed
consent to treatment.
Methods
Patients were recruited at the Child and Adolescent Neu-
ropsychiatry Inpatient Unit of the Umberto I Policlinic Hospital in
Rome. Parents or legal representative received full disclosure of the
aims of the study, and if agreed, patients received a full explanation
of the procedure as well. Informed consent for study participation
was obtained from parents and patients. The Institutional Review
Board approved the study. Diagnoses were made by the Diagnostic
and Statistical Manual of Mental Disorders, 5th edition (DSM-5)
(American Psychiatric Association 2013) criteria. All of the ap-
proached patients agreed to participate.
Two trained research raters assessed TDMC by the Mac-CAT-T,
a semistructured interview that was developed on the basis of the
main facets of treatment-related decision-making, reflecting com-
monly applied legal standards for competence to consent to treat-
ment. MacCAT-T scoring followed the provided instruction
manual; higher scores indicate better TDMC. Administering the
MacCAT-T usually takes 20–35 minutes.
The MacCAT-T comprised four subscales: understanding,
appreciating, reasoning, and expressing a choice, which are rated
independently and do not concur to a total score, which is not
expected. The subscales investigate understanding and retaining
of the information disclosed about the disorder and treatment
main features, as well as presumed associated risks and benefits,
the subscale range is 0–6. Appreciating subscale assesses patient’s
agreement with the physician opinion about diagnosis (2 = agrees
with all disclosed disease features or provides reasonable contrary
arguments, 1 = partially recognizes disease features, and 0 = does
not recognize suffering from disease or provide delusional argu-
ments) and treatment (scoring similar to appreciating diagnosis,
max two points), the subscale range is 0–4. Patient’s ability to
provide a reasonable, logical, and coherent reason about her/his
treatment choices (including treatment refusal) is evaluated by the
reasoning subscale, the subscale range is 0–8. Reasoning subscale
scoring includes eliciting patients’ consequential and comparative
thinking and analyzing its logical consistency, as well as patient
capacity to indicate possible treatment/no-treatment conse-
quences on everyday life. Expressing a choice (rated 0–2) mea-
sures patient’s ability to express a clear and nonambivalent
treatment choice.
A total score for the MacCAT-T was not calculated as we fo-
cused on the four subscale scores according to the interview stan-
dard procedure. This method is in agreement with the interview
structure and with a multidimensional mental capacity approach,
which suggests that poor performance in just one facet/subscale
may imply incapacity even in the presence of a good performance
in other domains. Treatment information disclosed to the patients
during MacCAT-T sessions was based on patients’ current psy-
chopharmacological prescription, which had been previously de-
cided by the treating staff and not by the study staff. Such
information was collected before the interview by discussing it with
the treating staff and analyzing case notes and prescriptions.
Psychiatric symptom severity was assessed by the Brief Psy-
chiatric Rating Scale v4.0 (BPRS). Patients’ subjective symptom-
atology was assessed by the youth self-report (YSR). The Children’s
Global Assessment Scale measured global functioning. The
Table 1. Clinical and Sociodemographic Data
of Acutely Hospitalized Children and Adolescents
with Psychiatric Disorders
N 22
Age, years, mean (SD) 15.8 (1.6)
Age, years, min/max 11.4/18.0
Sex, M/F, n (%) 15/7 (68.2/31.8)
School discontinuation, n (%) 4 (18.2)
Economic family status, n (%)
Low 6 (27.3)
Medium 13 (59.1)
High 3 (13.6)
First hospitalization, n (%) 17 (77.3)
Length of hospitalization before
assessment, mean (SD), range
38.7 (30.0) 15–111
BPRS, mean (SD), range 45.3 (9.3) 28–64
CGAS, mean (SD), range 45.6 (12.3), 31–85
n (%)
Mean (SD),
range
MacCAT-T understanding scores
<2.1 1 (4.6) 4.4 (1.2), 1.9–6
2.1–3 3 (13.6)
3.1–4 3 (13.6)
4.1–5 8 (36.4)
5.1–6 7 (31.8)
MacCAT-T appreciating scores
0 1 (4.5) 1.7 (1.1), 0–4
1 2 (9.1)
2 6 (27.3)
3 6 (27.3)
4 7 (31.8)
MacCAT-T reasoning scores
1–2 4 (18.2) 4.6 (2.1), 1–8
3–4 7 (31.8)
5–6 6 (27.3)
7–8 5 (21.7)
MacCAT-T expressing a choice scores
0 2 (9.1) 1.5 (0.6), 0–2
1 6 (27.3)
2 14 (63.7)
WISC-III verbal,
mean (SD), range
98.2 (22.6), 63–140
WISC-III performance,
mean (SD), range
92.5 (17.8), 61–130
WISC-III total,
mean (SD)
95.0 (20.9), 61–139
YSR externalizing,
mean (SD)
63.5 (14.2)
YSR internalizing,
mean (SD)
68.8 (11.3)
YSR total, mean (SD) 67.2 (12.3)
MacCAT-T, MacArthur Competence Assessment Tool for Treatment;
BPRS, Brief Psychiatric Rating Scale v4.0; CGAS, Children’s Global
Assessment Scale; SD, standard deviation; WISC-III, Wechsler Intelli-
gence Scale for Children-III; YSR, youth self-report.
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Wechsler Intelligence Scale for Children-III (WISC-III) measured
cognitive functioning.
Data were analyzed using the Statistical Package for Social
Sciences, version 17.0. Correlation analysis was performed by
Spearman’s correlation coefficient. Kruskal–Wallis H test served to
evaluate differences in MacCAT-T subscale scores among diag-
nostic groups (schizophrenia spectrum disorders, mood disorders,
personality disorders).
Results
We recruited 22 consecutive patients aged 11–18 years (Table 1)
in 8 months. Thirty percent of patients suffered from bipolar and
related disorders, 29% depressive disorders, 23% schizophrenia
spectrum and other psychotic disorders, and 18% personality dis-
orders. The majority of patients were at their first hospitalization.
Eighty-one percent of patients received an association of more than
two psychiatric medications, including second-generation anti-
psychotics (45.5%), first-generation antipsychotics (13.6%), anti-
epileptic drugs used as mood stabilizers or lithium carbonate
(45.5%), selective serotonin reuptake inhibitors (32%), and
benzodiazepines (18%). There was a common use of off-label
prescriptions.
All the study patients successfully completed the MacCAT-T
interview. No patient completely lacked the capacity to understand
and retain diagnosis and treatment information (Table 1). Mean
MacCAT-T scores were also good for evaluating, reasoning, and
expressing a choice. Almost 50% of the patients scored in the
higher range of MacCAT-T reasoning (>5), thus providing evi-
dence of good capacity to rationally manipulate treatment-related
information and to draw adequate conclusions about possible
therapy effects in everyday life.
Nonetheless, 41% of the patients showed moderate to severe
impairment in the ability of adequately recognizing their diagnosis/
symptoms as well as possible treatment implications as indicated
by an appreciating score lower than 2 (Table 1). Thirty-six percent
of the study patients were not able to express a clear and non-
ambivalent treatment choice, as indicated by having scored 0 or 1 at
MacCAT-T expressing a choice (Table 1). Kruskal–Wallis H test
disclosed no significant differences in capacity to consent to
treatment among diagnostic groups as measured by the MacCAT-T
scales.
Cognitive functioning varied widely within the study sample
(median intelligence quotient [IQ] = 93, first quartile IQ= 76.75,
third quartile IQ = 110.25). Three patients had an IQ below 70, one
patient fulfilled DSM-5 criteria for mild intellectual disability.
Spearman’s rho disclosed significant correlations between cog-
nitive measures and MacCAT-T understanding and reasoning scales
(Table 2). A negative association between excitement/mania (BPRS)
and understanding of treatment information emerged (Spearman’s
rho=-0.498, p< 0.05). Patients’ reporting of higher emotional and
behavioral problems (YSR) was associated with reduced capacity to
express a clear treatment choice (Table 2).
Discussion
Our results suggest the feasibility of the MacCAT-T for mea-
suring TDMC in child and adolescent psychiatric clinical samples.
To our knowledge, this is the first study indicating the possible
application of a well-established methodology for the evaluation of
informed consent of such clinical population. No modifications of
the published procedure were necessary.
A significant variability in TDMC emerged in the study sample,
a result similar to adult psychiatric populations. However, the
MacCAT-T mean values of the study sample were equal or slightly
higher to those obtained by a sample of acutely hospitalized adult
psychiatric inpatients (Mandarelli et al. 2014). These initial results
suggest that child and adolescent psychiatric populations might
Table 2. Correlations Between Treatment Decision-Making Capacity,
Clinical Measures, and Cognitive Functioning
MacCAT-T
Understanding Appreciating Reasoning Expressing a choice
BPRS total score -0.252 0.038 -0.150 -0.122
YSR externalizing -0.469* 0.104 -0.079 -0.322
YSR internalizing -0.80 -0.178 -0.078 -0.434*
YSR total -0.323 -0.112 -0.100 -0.481*
CGAS 0.083 0.289 0.273 0.113
WISC-III
Figures completion 0.568* 0.076 0.448 0.24
Information 0.611** 0.335 0.637** 0.361
Digit symbol coding 0.378 0.319 0.339 0.156
Similarities 0.626** 0.292 0.518* 0.409
Picture arrangement 0.374 0.081 0.287 -0.144
Arithmetic 0.596** 0.129 0.429 0.271
Block design 0.527* 0.371 0.750** 0.054
Vocabulary 0.617** 0.105 0.446 0.099
Object assembly 0.439 -0.048 0.254 -0.187
Comprehension 0.504* -0.035 0.384 0.328
Performance IQ 0.723** 0.280 0.592** 0.170
Verbal IQ 0.599** 0.210 0.522* 0.450
Total IQ 0.680** 0.215 0.532* 0.270
*p < 0.05; **p< 0.01; p values by Spearman’s rho. Significant correlations are in bold.
MacCAT-T, MacArthur Competence Assessment Tool for Treatment; BPRS, Brief Psychiatric Rating Scale v4.0; CGAS, Children’s Global
Assessment Scale; WISC-III, Wechsler Intelligence Scale for Children-III; YSR, youth self-report.
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present higher than expected TDMC. Noteworthy from a legal
standpoint, all the study patients were considered incompetent as
they were underage and hospitalization was decided by their par-
ents or other surrogate decision-makers. Further studies providing
external criterion validity (e.g., forensic psychiatrist judgments),
including nonpsychiatric populations, will help in clarifying whe-
ther and how child and adolescent decisional capacity could be
adequate also from a legal perspective. Our data suggest that severe
mental disorders are not definitely associated with impaired treat-
ment decision-making in child and adolescent psychiatry.
The ability to encode and retain information from the sur-
rounding environment, the skills of concrete and abstract thinking,
verbal competence, as well as the ability of planning and organi-
zation, are associated with the ability to rationally decide about own
treatment in adolescents affected by severe mental disorders.
These data seem to confirm that cognitive domains are deeply
associated with decision-making underlying treatment choices, also
in children and adolescents. The correlation analyses (Table 2)
showed several associations between WISC-III subscales and
MacCAT-T understanding and reasoning. The lack of associa-
tions we found with two other MacCAT-T subscales (appreciating
and expressing a choice) should be interpreted cautiously and
needs further investigation as might be consequent to type II error
in our study.
The subtest information, similarities, and vocabulary were highly
correlated with the MacCAT-T understanding. This result can be
interpreted in the light of a specific role played by neuropsycholo-
gical functions such as discernment, confrontation, verbal memory,
and visuospatial definition for this TDMC dimension. Block design
correlated significantly (rho= 0.75, p< 0.01) with MacCAT-T rea-
soning, together with WISC-III information and similarities. The
result seems to underline the importance of nonverbal mechanisms
of conceptualization as well as planning and general organization.
Executive functions, which are an acknowledged factor in adult
TDMC (Mandarelli et al. 2012), are of great importance also in child
and adolescent informed consent decision-making.
The lack of associations we found with MacCAT-T appreciating
deserves further investigation as it seems that this TDMC facet
might be specifically impaired in the study population due to
noncognitive, but affective, factors.
This study has limitations; first, the small sample size impairs the
possibility to generalize the study results. The single-center nature of
the study requires further assessment in different clinical settings.
Conclusions
The TDMC is feasibly measurable in a child and adolescent
neuropsychiatric setting with the MacCAT-T. Even though the
majority of democratic countries call for surrogate treatment
decision-making in minors, the initial data we provide here suggest
possible good TDMC in children and adolescents affected by
psychiatric disorders. Further studies should focus on TDMC in
larger and nonpsychiatric samples. Our preliminary results indicate
the need for enhancing the interplay between minors and surrogate
decision-makers as concerning treatment decisions.
Clinical Significance
To our knowledge, this is the first study providing empirical data
about TDMC in a child and adolescent clinical sample. Our results
suggest that TDMC in minors might be greater than expected and
deeply associated with cognitive functioning.
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